Associated Papers
Neurodevelopmental Implications Underpinning Hereditary Spastic Paraplegia.
Zhi Y et al.
Cns Neuroscience & Therapeutics, 2025
39932116 (PubMed )
Supplement: CNS-31-e70260-s001.xlsx › SPG4
FBXL17/spastin axis as a novel therapeutic target of hereditary spastic paraplegia.
Kang HM et al.
Cell & Bioscience, 2022
35869491 (PubMed )
Supplement: 13578_2022_851_MOESM2_ESM.docx
Defects in ER-endosome contacts impact lysosome function in hereditary spastic paraplegia.
Allison R et al.
The Journal of Cell Biology, 2017
Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses.
Ishiura H et al.
Journal of Human Genetics, 2016
Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses.
Ishiura H et al.
Journal of Human Genetics, 2014
A high-throughput resequencing microarray for autosomal dominant spastic paraplegia genes.
Dufke C et al.
Neurogenetics, 2012
Select a paper to view details